文献速递系统性红斑狼疮

西班牙大型系统性红斑狼疮队列中胃肠道表现的相关性:我们了解什么?

Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know?
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

基于RELESSER队列3658例符合ACR-97标准的SLE患者,回顾性多中心横断面研究显示3.7%发生胃肠道损伤,该组年龄更大、病程更长,更常合并血管炎、肾脏病和浆膜炎,住院率和死亡率显著更高,改良SDI更高;口服溃疡使损伤风险降低33%。

要点

  • SLE患者胃肠道损伤发生率3.7%,与更差预后相关。
  • 胃肠道损伤组住院率和死亡率显著更高,改良SDI更高。
  • 高剂量糖皮质激素增加胃肠道损伤风险,口腔溃疡降低风险33%。

核心结论

  • SLE患者发生胃肠道损伤与更差预后相关,高剂量糖皮质激素增加胃肠道损伤风险,口腔溃疡似乎降低胃肠道损伤风险。

研究设计与样本

  • 西班牙风湿病学会SLE患者注册队列(RELESSER)的全国性、回顾性、多中心、横断面队列研究,纳入3658例符合≥4项ACR-97标准的SLE患者。

主要发现

  • 3654例狼疮患者中3.7%发生胃肠道损伤。
  • 胃肠道损伤组患者年龄更大、病程更长,更常合并血管炎、肾脏病和浆膜炎。
  • 胃肠道损伤组住院率和死亡率显著更高,改良SDI更高。
  • 口服溃疡使患者发生损伤的风险降低33%。

关键数值与推荐

  • 胃肠道损伤组改良SDI(SLICC损伤指数)更高。
  • 口服溃疡使损伤风险降低33%。

临床怎么用

  • 对SLE患者应关注胃肠道损伤,高剂量糖皮质激素者需警惕胃肠道损伤风险,强化糖皮质激素减量策略。

局限性

  • 回顾性、横断面设计,无法确定因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: SLE can affect any part of the gastrointestinal (GI) tract. GI symptoms are reported to occur in >50% of SLE patients. To describe the GI manifestations of SLE in the RELESSER (Registry of SLE Patients of the Spanish Society of Rheumatology) cohort and to determine whether these are associated with a more severe disease, damage accrual and a worse prognosis. METHODS: We conducted a nationwide, retrospective, multicentre, cross-sectional cohort study of 3658 SLE patients who fulfil ≥4 ACR-97 criteria. Data on demographics, disease characteristics, activity (SLEDAI-2K or BILAG), damage (SLICC/ACR/DI) and therapies were collected. Demographic and clinical characteristics were compared between lupus patients with and without GI damage to establish whether GI damage is associated with a more severe disease. RESULTS: From 3654 lupus patients, 3.7% developed GI damage. Patients in this group (group 1) were older, they had longer disease duration, and were more likely to have vasculitis, renal disease and serositis than patients without GI damage (group 2). Hospitalizations and mortality were significantly higher in group 1. Patients in group 1 had higher modified SDI (SLICC Damage Index). The presence of oral ulcers reduced the risk of developing damage in 33% of patients. CONCLUSION: Having GI damage is associated with a worse prognosis. Patients on a high dose of glucocorticoids are at higher risk of developing GI damage which reinforces the strategy of minimizing glucocorticoids. Oral ulcers appear to decrease the risk of GI damage.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Tejera Segura B, Altabás González I, Rúa-Figueroa I, et al. Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know? Rheumatology (Oxford). 2021. PMID: 33950249. doi:10.1093/rheumatology/keab401

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。